The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
The second dose is on day 29 which has already passed for some patients and the third dose will be given on day 113 (jan 26)
“COVIDITY consists of two doses of the plasmid DNA vaccine SCOV1 (administered on Day 1 and Day 29), followed by two doses of the plasmid DNA vaccine SCOV2 (not before Days 113 and 141 [doses 4 weeks apart])”
Morning C7, no surprise at all that the sp is rising. We are due the interim results from the covid trial in the next few weeks that in itself should propel the sp higher from here.
Not to mention that the modi1 trial is about to start and we could get a deal any time now for the mabs.
A very exciting time to be a SCLP holder.
https://www.express.co.uk/news/science/1544345/covid-warning-new-variant-detected-southern-france-coronavirus-cases-uk-cameroon
"Emergence in southern France of a new SARS2 variant, B1.640.2, aka IHU.
"Experts believe it to be as transmissible as Delta but causing more severe disease and more immune evasive than the former VOC.
https://www.express.co.uk/news/science/1543223/covid-news-latest-flurona-israel-coronavirus-and-flu-pandemic-fears
If only there was a company that was targeting all past and future corona viruses ?????